The pro-remyelination properties of microglia in the central nervous system.


Journal

Nature reviews. Neurology
ISSN: 1759-4766
Titre abrégé: Nat Rev Neurol
Pays: England
ID NLM: 101500072

Informations de publication

Date de publication:
08 2019
Historique:
pubmed: 1 7 2019
medline: 28 1 2020
entrez: 1 7 2019
Statut: ppublish

Résumé

Microglia are resident macrophages of the CNS that are involved in its development, homeostasis and response to infection and damage. Microglial activation is a common feature of neurological disorders, and although in some instances this activation can be damaging, protective and regenerative functions of microglia have been revealed. The most prominent example of the regenerative functions is a role for microglia in supporting regeneration of myelin after injury, a process that is critical for axonal health and relevant to numerous disorders in which loss of myelin integrity is a prevalent feature, such as multiple sclerosis, Alzheimer disease and motor neuron disease. Although drugs that are intended to promote remyelination are entering clinical trials, the mechanisms by which remyelination is controlled and how microglia are involved are not completely understood. In this Review, we discuss work that has identified novel regulators of microglial activation - including molecular drivers, population heterogeneity and turnover - that might influence their pro-remyelination capacity. We also discuss therapeutic targeting of microglia as a potential approach to promoting remyelination.

Identifiants

pubmed: 31256193
doi: 10.1038/s41582-019-0184-2
pii: 10.1038/s41582-019-0184-2
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

447-458

Subventions

Organisme : Medical Research Council
ID : MR/M020827/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N022556/1
Pays : United Kingdom

Auteurs

Amy F Lloyd (AF)

Medical Research Council Centre for Reproductive Health, Multiple Sclerosis Society Edinburgh Centre for Multiple Sclerosis Research, The Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, UK.

Veronique E Miron (VE)

Medical Research Council Centre for Reproductive Health, Multiple Sclerosis Society Edinburgh Centre for Multiple Sclerosis Research, The Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, UK. vmiron@ed.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH